Juva Life Inc.
Juva Life Inc. JUVAF Peers
See (JUVAF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JUVAF | $0.00 | +11900.00% | 196.9K | -0.12 | -$0.01 | N/A |
| CHALF | $0.38 | +3799900.00% | 441.8B | -4.75 | -$0.08 | N/A |
| STMH | $0.10 | +99900.00% | 126.4B | -0.05 | -$1.89 | N/A |
| THCBF | $0.02 | +2350.00% | 59B | -2.45 | -$0.01 | N/A |
| MKGAF | $133.87 | +0.28% | 58.2B | 17.95 | $7.46 | +1.63% |
| MKKGY | $25.66 | -3.24% | 56.3B | 17.22 | $1.49 | +2.25% |
| TKPHF | $32.13 | +13.65% | 50.6B | 68.36 | $0.47 | +4.14% |
| HLNCF | $5.33 | -2.02% | 48B | 25.38 | $0.21 | +2.05% |
| KHRNF | $0.01 | +79900.00% | 42.2B | -0.80 | -$0.01 | N/A |
| IPSEY | $30.11 | +0.89% | 39.8B | 24.68 | $1.22 | +0.75% |
Stock Comparison
JUVAF vs CHALF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CHALF has a market cap of 441.8B. Regarding current trading prices, JUVAF is priced at $0.00, while CHALF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CHALF's P/E ratio is -4.75. In terms of profitability, JUVAF's ROE is -0.87%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs STMH Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, STMH has a market cap of 126.4B. Regarding current trading prices, JUVAF is priced at $0.00, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas STMH's P/E ratio is -0.05. In terms of profitability, JUVAF's ROE is -0.87%, compared to STMH's ROE of -2.75%. Regarding short-term risk, JUVAF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs THCBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, THCBF has a market cap of 59B. Regarding current trading prices, JUVAF is priced at $0.00, while THCBF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas THCBF's P/E ratio is -2.45. In terms of profitability, JUVAF's ROE is -0.87%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, JUVAF and THCBF have similar daily volatility (0.00).
JUVAF vs MKGAF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, MKGAF has a market cap of 58.2B. Regarding current trading prices, JUVAF is priced at $0.00, while MKGAF trades at $133.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas MKGAF's P/E ratio is 17.95. In terms of profitability, JUVAF's ROE is -0.87%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, JUVAF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs MKKGY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, MKKGY has a market cap of 56.3B. Regarding current trading prices, JUVAF is priced at $0.00, while MKKGY trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas MKKGY's P/E ratio is 17.22. In terms of profitability, JUVAF's ROE is -0.87%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, JUVAF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs TKPHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TKPHF has a market cap of 50.6B. Regarding current trading prices, JUVAF is priced at $0.00, while TKPHF trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TKPHF's P/E ratio is 68.36. In terms of profitability, JUVAF's ROE is -0.87%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, JUVAF and TKPHF have similar daily volatility (0.00).
JUVAF vs HLNCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HLNCF has a market cap of 48B. Regarding current trading prices, JUVAF is priced at $0.00, while HLNCF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HLNCF's P/E ratio is 25.38. In terms of profitability, JUVAF's ROE is -0.87%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, JUVAF and HLNCF have similar daily volatility (0.00).
JUVAF vs KHRNF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, KHRNF has a market cap of 42.2B. Regarding current trading prices, JUVAF is priced at $0.00, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, JUVAF's ROE is -0.87%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, JUVAF is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs IPSEY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, IPSEY has a market cap of 39.8B. Regarding current trading prices, JUVAF is priced at $0.00, while IPSEY trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas IPSEY's P/E ratio is 24.68. In terms of profitability, JUVAF's ROE is -0.87%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, JUVAF and IPSEY have similar daily volatility (0.00).
JUVAF vs EVRRF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, EVRRF has a market cap of 25.7B. Regarding current trading prices, JUVAF is priced at $0.00, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, JUVAF's ROE is -0.87%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, JUVAF is less volatile compared to EVRRF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SDZNY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SDZNY has a market cap of 22.3B. Regarding current trading prices, JUVAF is priced at $0.00, while SDZNY trades at $51.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SDZNY's P/E ratio is -2587.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SRUTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SRUTF has a market cap of 19.8B. Regarding current trading prices, JUVAF is priced at $0.00, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, JUVAF's ROE is -0.87%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, JUVAF is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs TEVJF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TEVJF has a market cap of 17.9B. Regarding current trading prices, JUVAF is priced at $0.00, while TEVJF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TEVJF's P/E ratio is -13.55. In terms of profitability, JUVAF's ROE is -0.87%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, JUVAF and TEVJF have similar daily volatility (0.00).
JUVAF vs ESALY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, JUVAF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ESALY's P/E ratio is 20.54. In terms of profitability, JUVAF's ROE is -0.87%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, JUVAF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SGIOY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SGIOY has a market cap of 14.5B. Regarding current trading prices, JUVAF is priced at $0.00, while SGIOY trades at $8.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SGIOY's P/E ratio is 12.36. In terms of profitability, JUVAF's ROE is -0.87%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, JUVAF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SGIOF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SGIOF has a market cap of 14.2B. Regarding current trading prices, JUVAF is priced at $0.00, while SGIOF trades at $16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SGIOF's P/E ratio is 12.14. In terms of profitability, JUVAF's ROE is -0.87%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, JUVAF and SGIOF have similar daily volatility (0.00).
JUVAF vs IPSEF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, JUVAF is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas IPSEF's P/E ratio is 25.74. In terms of profitability, JUVAF's ROE is -0.87%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, JUVAF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs RDDTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, RDDTF has a market cap of 9.9B. Regarding current trading prices, JUVAF is priced at $0.00, while RDDTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to RDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs BIOVF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, JUVAF is priced at $0.00, while BIOVF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BIOVF's P/E ratio is 22.69. In terms of profitability, JUVAF's ROE is -0.87%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, JUVAF and BIOVF have similar daily volatility (0.00).
JUVAF vs NOBDF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, JUVAF is priced at $0.00, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas NOBDF's P/E ratio is N/A. In terms of profitability, JUVAF's ROE is -0.87%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, JUVAF is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs ESALF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ESALF has a market cap of 8.4B. Regarding current trading prices, JUVAF is priced at $0.00, while ESALF trades at $29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ESALF's P/E ratio is 26.41. In terms of profitability, JUVAF's ROE is -0.87%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, JUVAF and ESALF have similar daily volatility (0.00).
JUVAF vs SFOSF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, JUVAF is priced at $0.00, while SFOSF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SFOSF's P/E ratio is 13.40. In terms of profitability, JUVAF's ROE is -0.87%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, JUVAF and SFOSF have similar daily volatility (0.00).
JUVAF vs ESAIY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ESAIY has a market cap of 7.8B. Regarding current trading prices, JUVAF is priced at $0.00, while ESAIY trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ESAIY's P/E ratio is 24.39. In terms of profitability, JUVAF's ROE is -0.87%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, JUVAF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs HKMPY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, JUVAF is priced at $0.00, while HKMPY trades at $56.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HKMPY's P/E ratio is 17.66. In terms of profitability, JUVAF's ROE is -0.87%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, JUVAF and HKMPY have similar daily volatility (0.00).
JUVAF vs GZPHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, GZPHF has a market cap of 6.1B. Regarding current trading prices, JUVAF is priced at $0.00, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, JUVAF's ROE is -0.87%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, JUVAF and GZPHF have similar daily volatility (0.00).
JUVAF vs HKMPF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, JUVAF is priced at $0.00, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, JUVAF and HKMPF have similar daily volatility (0.00).
JUVAF vs HLUBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HLUBF has a market cap of 5.3B. Regarding current trading prices, JUVAF is priced at $0.00, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HLUBF's P/E ratio is 10.65. In terms of profitability, JUVAF's ROE is -0.87%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, JUVAF and HLUBF have similar daily volatility (0.00).
JUVAF vs HLBBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, JUVAF is priced at $0.00, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HLBBF's P/E ratio is 12.45. In terms of profitability, JUVAF's ROE is -0.87%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, JUVAF and HLBBF have similar daily volatility (0.00).
JUVAF vs APNHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, JUVAF is priced at $0.00, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas APNHF's P/E ratio is 16.14. In terms of profitability, JUVAF's ROE is -0.87%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, JUVAF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs LVZPF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, LVZPF has a market cap of 4.1B. Regarding current trading prices, JUVAF is priced at $0.00, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, JUVAF's ROE is -0.87%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, JUVAF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs HYPMY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, JUVAF is priced at $0.00, while HYPMY trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HYPMY's P/E ratio is 21.81. In terms of profitability, JUVAF's ROE is -0.87%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, JUVAF and HYPMY have similar daily volatility (0.00).
JUVAF vs INVVY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, JUVAF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas INVVY's P/E ratio is -62.42. In terms of profitability, JUVAF's ROE is -0.87%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, JUVAF and INVVY have similar daily volatility (0.00).
JUVAF vs APNHY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, JUVAF is priced at $0.00, while APNHY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas APNHY's P/E ratio is 11.68. In terms of profitability, JUVAF's ROE is -0.87%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, JUVAF and APNHY have similar daily volatility (0.00).
JUVAF vs IZQVF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, JUVAF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, JUVAF's ROE is -0.87%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, JUVAF and IZQVF have similar daily volatility (0.00).
JUVAF vs WIBFF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, WIBFF has a market cap of 2.9B. Regarding current trading prices, JUVAF is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, JUVAF's ROE is -0.87%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs ULIHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, JUVAF is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, JUVAF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs HMDCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, JUVAF is priced at $0.00, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, JUVAF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs HTSUF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, JUVAF is priced at $0.00, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HTSUF's P/E ratio is 16.10. In terms of profitability, JUVAF's ROE is -0.87%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, JUVAF and HTSUF have similar daily volatility (0.00).
JUVAF vs DNPUF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, DNPUF has a market cap of 2.3B. Regarding current trading prices, JUVAF is priced at $0.00, while DNPUF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas DNPUF's P/E ratio is 14.15. In terms of profitability, JUVAF's ROE is -0.87%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, JUVAF and DNPUF have similar daily volatility (0.00).
JUVAF vs CHSYF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, JUVAF is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, JUVAF's ROE is -0.87%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, JUVAF and CHSYF have similar daily volatility (0.00).
JUVAF vs SHEZF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SHEZF has a market cap of 2.2B. Regarding current trading prices, JUVAF is priced at $0.00, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, JUVAF's ROE is -0.87%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, JUVAF and SHEZF have similar daily volatility (0.00).
JUVAF vs TSMRF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, JUVAF is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, JUVAF's ROE is -0.87%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, JUVAF and TSMRF have similar daily volatility (0.00).
JUVAF vs DMPHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, JUVAF is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, JUVAF's ROE is -0.87%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, JUVAF and DMPHF have similar daily volatility (0.00).
JUVAF vs LBTSF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, JUVAF is priced at $0.00, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas LBTSF's P/E ratio is 162.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, JUVAF and LBTSF have similar daily volatility (0.00).
JUVAF vs LJUIF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, JUVAF is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, JUVAF's ROE is -0.87%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, JUVAF and LJUIF have similar daily volatility (0.00).
JUVAF vs ARSUF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, JUVAF is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, JUVAF's ROE is -0.87%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, JUVAF and ARSUF have similar daily volatility (0.00).
JUVAF vs NPNKF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, NPNKF has a market cap of 1.8B. Regarding current trading prices, JUVAF is priced at $0.00, while NPNKF trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas NPNKF's P/E ratio is 7.81. In terms of profitability, JUVAF's ROE is -0.87%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, JUVAF and NPNKF have similar daily volatility (0.00).
JUVAF vs CHIZF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CHIZF has a market cap of 1.7B. Regarding current trading prices, JUVAF is priced at $0.00, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, JUVAF's ROE is -0.87%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, JUVAF and CHIZF have similar daily volatility (0.00).
JUVAF vs NPPNY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, NPPNY has a market cap of 1.7B. Regarding current trading prices, JUVAF is priced at $0.00, while NPPNY trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas NPPNY's P/E ratio is 7.36. In terms of profitability, JUVAF's ROE is -0.87%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, JUVAF and NPPNY have similar daily volatility (0.00).
JUVAF vs EVOTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, JUVAF is priced at $0.00, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, JUVAF's ROE is -0.87%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, JUVAF and EVOTF have similar daily volatility (0.00).
JUVAF vs SMDPY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, JUVAF is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, JUVAF's ROE is -0.87%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, JUVAF and SMDPY have similar daily volatility (0.00).
JUVAF vs MITPF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, JUVAF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas MITPF's P/E ratio is -10.81. In terms of profitability, JUVAF's ROE is -0.87%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, JUVAF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs YIHCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, JUVAF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, JUVAF and YIHCF have similar daily volatility (0.00).
JUVAF vs KARBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, JUVAF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas KARBF's P/E ratio is 262.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to KARBF's ROE of N/A. Regarding short-term risk, JUVAF and KARBF have similar daily volatility (0.00).
JUVAF vs TWAPF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, JUVAF is priced at $0.00, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, JUVAF's ROE is -0.87%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, JUVAF and TWAPF have similar daily volatility (0.00).
JUVAF vs GTBIF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, JUVAF is priced at $0.00, while GTBIF trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas GTBIF's P/E ratio is 23.57. In terms of profitability, JUVAF's ROE is -0.87%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, JUVAF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CASBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CASBF has a market cap of 1.1B. Regarding current trading prices, JUVAF is priced at $0.00, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CASBF's P/E ratio is -17.81. In terms of profitability, JUVAF's ROE is -0.87%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, JUVAF and CASBF have similar daily volatility (0.00).
JUVAF vs SWGHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, JUVAF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, JUVAF's ROE is -0.87%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, JUVAF and SWGHF have similar daily volatility (0.00).
JUVAF vs GNMLF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, JUVAF is priced at $0.00, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas GNMLF's P/E ratio is 9.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, JUVAF and GNMLF have similar daily volatility (0.00).
JUVAF vs SHPHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, JUVAF is priced at $0.00, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, JUVAF's ROE is -0.87%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, JUVAF and SHPHF have similar daily volatility (0.00).
JUVAF vs KSPHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, KSPHF has a market cap of 1B. Regarding current trading prices, JUVAF is priced at $0.00, while KSPHF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas KSPHF's P/E ratio is 12.55. In terms of profitability, JUVAF's ROE is -0.87%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, JUVAF and KSPHF have similar daily volatility (0.00).
JUVAF vs KKPCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, KKPCF has a market cap of 980.3M. Regarding current trading prices, JUVAF is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas KKPCF's P/E ratio is 10.54. In terms of profitability, JUVAF's ROE is -0.87%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, JUVAF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs BIOGY Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, JUVAF is priced at $0.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BIOGY's P/E ratio is 30.47. In terms of profitability, JUVAF's ROE is -0.87%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, JUVAF and BIOGY have similar daily volatility (0.00).
JUVAF vs NRXCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, NRXCF has a market cap of 853.3M. Regarding current trading prices, JUVAF is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, JUVAF's ROE is -0.87%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, JUVAF and NRXCF have similar daily volatility (0.00).
JUVAF vs ELTP Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ELTP has a market cap of 829.5M. Regarding current trading prices, JUVAF is priced at $0.00, while ELTP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ELTP's P/E ratio is -38.82. In terms of profitability, JUVAF's ROE is -0.87%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, JUVAF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CSWYF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, JUVAF is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, JUVAF's ROE is -0.87%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, JUVAF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs AGYTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, JUVAF is priced at $0.00, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, JUVAF's ROE is -0.87%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, JUVAF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs NIKA Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, JUVAF is priced at $0.00, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas NIKA's P/E ratio is N/A. In terms of profitability, JUVAF's ROE is -0.87%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, JUVAF and NIKA have similar daily volatility (0.00).
JUVAF vs TCNNF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TCNNF has a market cap of 697.4M. Regarding current trading prices, JUVAF is priced at $0.00, while TCNNF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TCNNF's P/E ratio is -4.62. In terms of profitability, JUVAF's ROE is -0.87%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, JUVAF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs TRXPF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, JUVAF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, JUVAF's ROE is -0.87%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, JUVAF and TRXPF have similar daily volatility (0.00).
JUVAF vs ABSCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ABSCF has a market cap of 682.7M. Regarding current trading prices, JUVAF is priced at $0.00, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, JUVAF's ROE is -0.87%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, JUVAF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SWDCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, JUVAF is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, JUVAF's ROE is -0.87%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, JUVAF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs LVTTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, LVTTF has a market cap of 664.6M. Regarding current trading prices, JUVAF is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, JUVAF's ROE is -0.87%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs BOIRF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, JUVAF is priced at $0.00, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, JUVAF's ROE is -0.87%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, JUVAF and BOIRF have similar daily volatility (0.00).
JUVAF vs CURLF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CURLF has a market cap of 617.3M. Regarding current trading prices, JUVAF is priced at $0.00, while CURLF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CURLF's P/E ratio is -2.47. In terms of profitability, JUVAF's ROE is -0.87%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, JUVAF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs TRSSF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, JUVAF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, JUVAF's ROE is -0.87%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, JUVAF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs SGFEF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, SGFEF has a market cap of 583.8M. Regarding current trading prices, JUVAF is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas SGFEF's P/E ratio is 25.19. In terms of profitability, JUVAF's ROE is -0.87%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, JUVAF and SGFEF have similar daily volatility (0.00).
JUVAF vs MNFSF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, JUVAF is priced at $0.00, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, JUVAF's ROE is -0.87%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, JUVAF is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CCHWF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, JUVAF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, JUVAF's ROE is -0.87%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, JUVAF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs AIHLF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, JUVAF is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, JUVAF's ROE is -0.87%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, JUVAF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs PEXXF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, JUVAF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to PEXXF's ROE of N/A. Regarding short-term risk, JUVAF and PEXXF have similar daily volatility (0.00).
JUVAF vs KHTRF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, KHTRF has a market cap of 447.8M. Regarding current trading prices, JUVAF is priced at $0.00, while KHTRF trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas KHTRF's P/E ratio is 64.21. In terms of profitability, JUVAF's ROE is -0.87%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, JUVAF and KHTRF have similar daily volatility (0.00).
JUVAF vs HUMDF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, JUVAF is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas HUMDF's P/E ratio is -10.27. In terms of profitability, JUVAF's ROE is -0.87%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, JUVAF and HUMDF have similar daily volatility (0.00).
JUVAF vs LRDSF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, LRDSF has a market cap of 381.9M. Regarding current trading prices, JUVAF is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, JUVAF's ROE is -0.87%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, JUVAF and LRDSF have similar daily volatility (0.00).
JUVAF vs EOFBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, EOFBF has a market cap of 333.2M. Regarding current trading prices, JUVAF is priced at $0.00, while EOFBF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas EOFBF's P/E ratio is -2.33. In terms of profitability, JUVAF's ROE is -0.87%, compared to EOFBF's ROE of -1.26%. Regarding short-term risk, JUVAF and EOFBF have similar daily volatility (0.00).
JUVAF vs BHCCF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, JUVAF is priced at $0.00, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, JUVAF's ROE is -0.87%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, JUVAF and BHCCF have similar daily volatility (0.00).
JUVAF vs BHHKF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BHHKF has a market cap of 293M. Regarding current trading prices, JUVAF is priced at $0.00, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, JUVAF's ROE is -0.87%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, JUVAF is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs PKBFF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, PKBFF has a market cap of 292.3M. Regarding current trading prices, JUVAF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, JUVAF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs ABTI Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, ABTI has a market cap of 291.9M. Regarding current trading prices, JUVAF is priced at $0.00, while ABTI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas ABTI's P/E ratio is -20.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, JUVAF and ABTI have similar daily volatility (0.00).
JUVAF vs GLASF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, GLASF has a market cap of 271.9M. Regarding current trading prices, JUVAF is priced at $0.00, while GLASF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas GLASF's P/E ratio is -55.56. In terms of profitability, JUVAF's ROE is -0.87%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CPHRF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CPHRF has a market cap of 246.7M. Regarding current trading prices, JUVAF is priced at $0.00, while CPHRF trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CPHRF's P/E ratio is 26.74. In terms of profitability, JUVAF's ROE is -0.87%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, JUVAF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs PSIQ Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, JUVAF is priced at $0.00, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas PSIQ's P/E ratio is N/A. In terms of profitability, JUVAF's ROE is -0.87%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, JUVAF is less volatile compared to PSIQ. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs PLNHF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, JUVAF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, JUVAF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs VRNOF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, VRNOF has a market cap of 179.9M. Regarding current trading prices, JUVAF is priced at $0.00, while VRNOF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas VRNOF's P/E ratio is -0.50. In terms of profitability, JUVAF's ROE is -0.87%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, JUVAF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs YOURF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, YOURF has a market cap of 178.2M. Regarding current trading prices, JUVAF is priced at $0.00, while YOURF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas YOURF's P/E ratio is 0.01. In terms of profitability, JUVAF's ROE is -0.87%, compared to YOURF's ROE of +0.00%. Regarding short-term risk, JUVAF is less volatile compared to YOURF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs WLDFF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, JUVAF is priced at $0.00, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas WLDFF's P/E ratio is N/A. In terms of profitability, JUVAF's ROE is -0.87%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, JUVAF is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CRLBF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CRLBF has a market cap of 162.1M. Regarding current trading prices, JUVAF is priced at $0.00, while CRLBF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CRLBF's P/E ratio is -2.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, JUVAF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs CBSTF Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, CBSTF has a market cap of 156.9M. Regarding current trading prices, JUVAF is priced at $0.00, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas CBSTF's P/E ratio is -0.22. In terms of profitability, JUVAF's ROE is -0.87%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, JUVAF is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for JUVAF.
JUVAF vs BKUH Comparison
JUVAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JUVAF stands at 196.9K. In comparison, BKUH has a market cap of 150.7M. Regarding current trading prices, JUVAF is priced at $0.00, while BKUH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JUVAF currently has a P/E ratio of -0.12, whereas BKUH's P/E ratio is -50.00. In terms of profitability, JUVAF's ROE is -0.87%, compared to BKUH's ROE of +0.10%. Regarding short-term risk, JUVAF and BKUH have similar daily volatility (0.00).